Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy of Dapagliflozin in the Treatment of Heart Failure in Non-diabetic Egyptian Patients

NCT05727423 is registered in ClinicalTrials.gov with Helwan University as lead sponsor.

NCT NCT05727423
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05727423 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy of Dapagliflozin in the Treatment of Heart Failure in Non-diabetic Egyptian Patients
Lead sponsor
Helwan University
Phase
Observational
Overall status
Unknown status
Start date
September 1, 2021
Completion date
February 1, 2024
Enrollment
45 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

heart failure